Follow
Oral cancer genomics
Oral cancers include those that impact the oral cavity, including the mouth, tongue, gums, and lips. Genomic studies have been used to understand genetic changes that occur when cancer is developed or when it grows. The cancer genome atlas (TCGA) included head and neck squamous cell carcinomas, and a majority of these cases were from oral cancer patients.
FEB 26, 2020 | 7:30 AM
Recent advances in DNA sequencing and omics-based capabilities are revealing incredible therapeutic opportunities and quickly transforming drug discovery. Molecularly targeted drugs aim to e...
JUN 20, 2019 | 9:00 AM
Recent advances in genomic technologies have revealed enormous complexities and uniqueness of human physiology. Although enormous efforts are being made to apply this knowledge to enhance the...
FEB 27, 2019 | 10:30 AM
Recent clinical successes in cancer genome-inspired personalized medicine have been a major breakthrough in drug discovery. However, 98% of the patients have an incomplete therapeutic respons...
OCT 11, 2018 | 12:00 PM
Although targeted therapies often elicit profound initial patient responses, these effects are transient due to residual disease leading to acquired resistance. How tumors transition between...
MAY 03, 2018 | 11:00 AM
DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
JAN 30, 2018 | 9:00 AM
DATE: January 30, 2018TIME: 9:00AM PST, 12:00PM ESTInfectious disease surveillance and monitoring is critical in settings where disease outbreaks and antibiotic resistance can dramatica...
NOV 02, 2016 | 1:30 PM
Today there are about 7B mobile phone worldwide and about 50,000 mobile health applications actively changing the landscape of how healthcare will be delivered in the next years. While numero...
APR 06, 2016 | 6:00 AM
The advent of personalized medicine employing molecular targeted therapies has markedly changed the treatment of cancer in the past 10 years. Although tumor tissue biopsy-based genotyping is...
MAY 29, 2014 | 12:00 PM
Pharmcogenomics (PGx) is the 2nd potential clinical application of genomic medicine, preceded by genomic application for cancer. In the recently published, 2012 Institute of Medicine report o...